Symbol
| CAV3
| contributors: mct/npt - updated : 17-03-2017
|
HGNC name
| caveolin 3
|
HGNC id
| 1529
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
constitutional
|  
|  
| --over
|  
|
with presenilin in astrocytes of Alzheimer disease and leading to alteration of APP processing | constitutional
|  
|  
| --over
|  
|
in skeletal muscle fibers inducing a muscular dystrophy Duchenne-like | constitutional
|  
|  
| --over
|  
|
in idiopathic hyper-CK-emia | constitutional
|  
|  
|  
| loss of function
|
palmitate-induced loss of CAV3 results in cardiac contractile dysfunction via a defect in calcium-induced calcium release | |
Susceptibility
|
to cardiac death |
Variant & Polymorphism
other
| CAV3 V82I variant on cell viability may participate in determining the susceptibility to cardiac death |
|
|
Candidate gene
Marker
Therapy target
| | | |
| caveolin-3 null mice show abnormal neuromuscular junction activity that is consistent with altered CHRNA4 localization at the sarcolemma (Hezel 2010) | |
caveolin-3 knockout (Cav-3KO) mice exhibited modestly increased myocardial ischemia/reperfusion injury (increased infarct size, apoptosis, and poorer cardiac function recovery |